Exploring emotional regulation in schizophrenia
Official title: Qualitative Study of Emotional Regulation in Schizophrenia
Run by University Hospital, Grenoble · NCT06275451 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to understand how people with schizophrenia manage their emotions by listening to their personal stories and experiences.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 2 sites (La Tronche and 1 other locations) |
| Trial ID | NCT06275451 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 60 with a diagnosis of schizophrenia or schizoaffective disorder who can communicate in French.
✕Probably not a fit
Patients experiencing significant psychological instability or with neurological comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate emotional regulation in individuals diagnosed with schizophrenia or schizoaffective disorder through qualitative methods, specifically using semi-structured interviews. The focus is on understanding patients' perspectives regarding their emotional regulation strategies, which may be adaptive or maladaptive. By examining these personal narratives, the study seeks to highlight the emotional regulation difficulties that are often overlooked in quantitative research. The findings could provide insights into the contextual factors influencing emotional regulation in psychosis.
Why it matters
Potential benefit: If successful, this study could enhance understanding of emotional regulation in schizophrenia, potentially leading to improved therapeutic approaches.
How similar studies have gone: While qualitative studies on emotional regulation in psychosis are less common, existing literature suggests that exploring patient perspectives can yield valuable insights, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Schizophrenia or schizoaffective disorder verified using the criteria of the M.I.N.I. (Mini International Neuropsychiatric Interview) scale (First, Spitzer, Gibbon, Williams, \& others, 1995) based on the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) (Association \& others, 2013). * Patient in free care, under psychiatric care at the request of a third party or under curatorship. In the case of patients under curatorship, the investigator will inform the curator of the participant's non-opposition and therefore of his or her participation in the research. * Able to read, understand and speak French. * Age ≥ 18 years and \< 60 years * Must consent to the study and be able to give oral non-opposition. Exclusion Criteria: * Psychological instability (i.e., Agitation or major suicidal risk on clinical examination by psychiatrist prior to study entry). * Neurological history/comorbidity (head injury, epilepsy, multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, stroke).
Where it's running
-
Chuga
La Tronche, France Recruiting -
C3r
Saint-Martin-d'Hères, France Recruiting
Study contacts
- Principal investigator: Clément Dondé — University Grenoble, Hospital
- Study coordinator: Clément Dondé
- Email: cdondecoquelet@chu-grenoble.fr
- Phone: 04-76-76-39-86
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Lumateperone to improve motivation in patients with schizophrenia and psychosis
This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
XEP527 in stable schizophrenia: safety and how it behaves in the body
This small, early-stage study tests the safety and how XEP527 behaves in people with stable schizophrenia who are on a single antipsychotic.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Quality of life and safety in quetiapine use for schizophrenia or bipolar disorder
This study looks at how patients with schizophrenia or bipolar disorder feel and stay safe when treated with quetiapine alone or with other antipsychotics.
-
Neuronavigated rTMS for treatment-resistant auditory hallucinations
We are testing whether personalized neuronavigated inhibitory rTMS can reduce persistent auditory verbal hallucinations in adults who don’t respond to medication.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.